Abstract
In many European countries, obstetric ultrasound (US) is performed routinely during normal pregnancies. This leads to the discovery of many fetal anomalies, and, among them, uro-nephropathies represent one of the largest groups amenable to neonatal management. They are now included in the so-called CAKUT [congenital anomalies of the kidney and urinary tract] group (Renkema et al. 2011; Wiesel et al 2005; Ek et al. 2007).
Access provided by CONRICYT-eBooks. Download chapter PDF
Similar content being viewed by others
1 Introduction
In many European countries, obstetric ultrasound (US) is performed routinely during normal pregnancies. This leads to the discovery of many fetal anomalies, and, among them, uro-nephropathies represent one of the largest groups amenable to neonatal management. They are now included in the so-called CAKUT [congenital anomalies of the kidney and urinary tract] group (Renkema et al. 2011; Wiesel et al 2005; Ek et al. 2007).
Changes have occurred in the neonatal management since nowadays these uropathies are detected in mostly asymptomatic patients, and the treatment is mainly preventive. Antenatal detection and postnatal follow-up have yielded new data on the natural history of many uropathies and have shown that a majority of antenatally diagnosed renal dilatations will resolve spontaneously (Barbosa et al. 2012; Ek et al. 2007; Kumar et al. 2012; Quirino et al. 2012; Wollenberg et al. 2005).
The aims of the postnatal work-up will be first to confirm the anomaly, to ascertain the diagnosis (and the prognosis), then to adapt the follow-up to the type of anomaly, and finally to decide on the best treatment (see also chapter “Congenital Urinary Tract Dilatation and Obstructive Uropathy”). The rationale of all the imaging is clearly to prevent further complications on an already damaged kidney (Ismaïli et al. 2004, 2005).
2 Postnatal Work-Up
The ideal postnatal work-up is still debated but it has been markedly standardized. At first the antenatal US findings were standardized (Table 1) differentiating minimal and moderate dilatation from marked dilatation in order to define the proper postnatal management. Secondly the postnatal management has been also standardized depending on the antenatal and postnatal findings (Tables 2a and 2b). All proposed managements are based on the US findings (Riccabona et al. 2008, 2009).
An American consensus panel has recently proposed a further classification and standardization: the UTD (urinary tract dilatation) classification system aimed to describe simultaneously both antenatally and postnatally US findings. It is based on six US findings, anterior-posterior (AP) axial renal pelvic dilatation, calyceal dilatation, renal parenchymal thickness, parenchymal appearance, bladder and ureteral anomalies, as well as the amniotic fluid volume. The system distinguishes whether the findings are antenatal (A) or postnatal (P) followed by a number. UTD A1 represents mild antenatal UTD and UTD P3 marked postnatal dilatation (Nguyen et al. 2014). The examination is intended to confirm the anomaly, differentiate between uro- and nephropathies (knowing that both can be associated), and determine the need for further imaging. Voiding cystourethrography (VCUG) looking for vesicoureteric reflux (VUR) and functional studies (scintigraphy, MRI) will be used afterward as required (Ismaili et al. 2006; Riccabona et al. 2008, 2009; Nguyen et al. 2014).
2.1 Clinical Situations and Antenatal Diagnoses Necessitating a Rapid Management
After birth, severe bilateral renal diseases (renal hypoplasia, posterior urethral valves, polycystic kidney diseases, etc.) can be associated with pneumothorax, lung hypoplasia, and life-threatening respiratory distress (Fig. 1). A respiratory assistance is mandatory even before considering any treatment for the urinary tract anomaly. Conversely, whenever a neonate presents massive – seemingly – spontaneous pneumothorax, an US examination should be performed in order to verify the status of the urinary tract.
Several other conditions could necessitate early management and workup in the immediate neonatal period. In posterior urethral valves (Fig. 2), the rapid placement of a bladder catheter (suprapubic or urethral) will help to decrease the high bladder pressure, before valve resection. An ectopic ureterocele associated with an obstructed upper pole of a duplex kidney is prone to prolapse into the urethra during micturition and to provoke acute bladder outlet obstruction (Fig. 3). Cystoscopic unroofing the ureterocele is therefore advocated as the first step in managing this type of duplex kidneys (Uphadhyay et al. 2002; Van Savage and Mesrobian 1995; Hagg et al. 2000) (Fig. 4). Markedly dilated urinary tract (giant pelvi-ureteric junction obstruction) may cause uncomfortable enlargement of the baby’s abdomen and interfere with normal bowel transit, and then early nephrostomy or nephrectomy may become indicated (Fig. 5) (Shimada et al. 2007). Once all necessary therapeutic measures are taken, the work-up can restart more classically.
2.2 Postnatal Work-Up of Uropathies
As mentioned, the aims of postnatal work-up are to ascertain the diagnosis of the uropathy, determine the degree of “obstruction” and/or renal function impairment, as well as the presence of VUR.
For all uropathies, the workup has been markedly standardized. Nowadays, the major workload of an imaging department dealing with neonatal pathology is related to the management of antenatally diagnosed urinary tract dilatation and its significance. Noteworthy, the extensive neonatal workup performed in recent years by many teams has increased mainly the detection of neonatal VUR, with questionable impact on management in quite a few of these infants (Van Eeide et al. 2007; Ismaïli et al. 2006).
Two work-up approaches have been proposed. For some authors, whatever the result of a neonatal US, a VCUG should be performed in case of any antenatal urinary tract dilatation. For them, US is a poor predictor of VUR (Tibballs and De Bruyn 1996; Walsh and Dubbins 1996). For others, a VCUG should not be performed in all neonates; there will be too many unnecessary negative VCUGs. A VCUG should be performed only in those patients in whom the anomaly has been confirmed after birth (Yerkes et al. 1999). We favor the second approach and recommend a decision tree based on the neonatal and follow-up US findings (Riccabona et al. 2008, 2009) (Tables 2a and 2b). Hence, US is performed first in order to confirm the anomaly (Fig. 6) (Marra et al. 1994; Avni et al. 1997; Hulbert et al. 1992). In any urgent situation and in all cases where the dilatation is known to be marked, it can be performed as soon as the clinical condition permits. For all other cases, it should be delayed to the post physiological dehydration period, namely, after the fifth day of life. At that time, the US examination should be as detailed as possible in order to detect every anomaly that would justify continuing the work-up (Table 3). The presence of a urinary tract dilatation is the most important landmark; seven mm is the most widely accepted upper limit of normal (some prefer 5 mm, others 10 mm or even 12 mm) in the second and third trimester, respectively. Higher degrees of dilatation are associated with higher probability of a significant uropathy. Still, dilatation of the renal pelvis is not the only anomaly that should be looked for. Other US features can be associated with VUR or “obstruction” (Table 2b). One should not forget to examine the bladder; a large bladder with a thickened and trabeculated wall could be a sign of VUR (Fig. 7). With a meticulous US examination, one should be able to detect indirect signs for VUR in over 85 % of cases. Those VURs that are missed are non-dilating or grade I–II VURs with less clinical significance (Nguyen et al. 2014; Pates and Dashe 2006; Weinberg and Yeung 1998; Ismaïli et al. 2004; Bouzada et al. 2004). Finally, particularly in baby boys, the comprehensive US study should include a perineal scan of the urethra during voiding – particularly if indirect signs suggest a possible posterior urethral valve.
If the initial US examination is entirely normal, it seems reasonable to perform follow-up examinations at 1 or 3 months in order to detect cases that would have escaped the neonatal screening (Riccabona et al. 2008, 2009) (Tables 2a and 2b).
In case of an abnormal US, a VCUG (or ce.-VUS) should be performed, preferably during the first weeks of life. The examination may be performed under prophylactic antibiotic therapy. The aim of the examination is to detect VUR and bladder or urethral anomalies.
If high-grade VUR is demonstrated, the patient is followed up clinically hoping that the VUR will resolve spontaneously. During this period of time, renal growth can be monitored every 3–6 months using US. The persistence of VUR should be verified if infections occur or in the absence of renal growth (Kousidis et al. 2008).
If no VUR is present, marked dilatation can be associated with urinary drainage impairment (possibly obstruction) at the level of the pelvi-ureteric junction, the ureterovesical junction, or below the bladder outlet. US will help to determine the level of obstruction. In some centers, the work-up will be completed by functional studies, including a furosemide nephrogram – especially in cases with severe dilatation (Morris et al. 2009) (see below).
2.3 Further Anatomical Assessment
If drainage impairment seems important and surgery may become indicated, the exact anatomy of the urinary tract must be assessed. Intravenous urography is no longer performed and MR urography is the best technique available to evaluate the anatomy of the urinary tract (Fig. 8). It will assess most precisely the anatomy of the dilated urinary tract (Avni et al. 2000; Darge et al. 2013). Furosemide is usually injected in order to increase diuresis and thus to optimize visualization of the entire collecting and draining system. T2 sequences, inversion recovery sequences, and post-gadolinium enhancement 3D-T1 sequences allow a good evaluation of the entire urinary tract (see chapter “MR of the Urogenital Tract in Children”). The only drawback of the method is that it may require sedation and that it is not widely available.
In case of a duplex collecting system, the work-up is similar to that for obstruction, except that the morphological assessment must be more rapid since an early therapeutic maneuver may become necessary. Again US, VCUG/ce-VUS, and MR urography will optimally evaluate the exact morphology (Fig. 9). MR urography demonstrates accurately the extravesical insertion of an ectopic ureter (Avni et al. 2000; Adeb et al. 2013). An isotope study, using preferably Tc99m MAG 3 or Tc99m ECD, is also mandatory in order to evaluate the remaining function of the two moieties (Piepsz and Ham 2006; Adeb et al. 2013) (see below, and chapter “Nuclear Medicine”).
2.4 Functional Assessment: Nuclear Medicine Studies
Radionuclide renogram may be performed starting at 4–6 weeks – ideally around 3–6 months – but in cases of severe dilatation, it may be performed as early as 3–4 days of age (Piepsz et al. 2009; Ismaili and Piepsz 2013). In very young infants, in case of impaired overall GFR or in case of important renal pelvic dilatation, the determination of the differential renal function (DRF) has a poor accuracy (Piepsz et al. 2009). In such situations, the aim will essentially be to roughly estimate the function and drainage impairment of the affected kidney (Piepsz et al. 2011) (Fig. 10). Tubular tracers (Tc99m MAG 3 or Tc99m ECD) are currently recommended, especially in young patients, because their high extraction rate allows accurate quantification of the renogram (Ismaili and Piepsz 2013; Piepsz et al. 2009; Gordon et al. 2001, 2011) (Fig. 10). The same radiopharmaceutical should be used for the follow-up studies (Piepsz et al. 2009). The radiation dose delivered is low, between 0.2 and 0.4 mSv (Stabin et al. 1992; Smith and Gordon 1998; Ismaili 2013). Determining DRF in infants is less precise than in older children; DRF are evaluated from the early phase of the renogram. Normal values are between 45 and 55 % (Gordon et al. 2011; Prigent et al. 1999; Eskild-Jensen et al. 2004). Drainage stimulation, using furosemide, is the procedure of choice to obtain information about renal drainage. Furosemide (1 mg/kg body weight, up to 20 mg) is often injected simultaneously with the radiopharmaceutical agent (“F0 protocol”), reducing the duration of the examination and the number of venous punctures (Piepsz et al. 2011); however, it needs sufficient renal maturity and functional capacity to be effective, as well as sufficient/physiological hydration for the study. A full bladder at the end of the renogram may result in a poor drainage; therefore, post-micturition images obtained in an erect position if possible are mandatory (Gordon et al. 2011; Piepsz et al. 2009, 2011; Ismaili and Piepsz 2013). The evaluation of renal drainage is essentially based upon output efficiency (OE) and normalized residual activity (NORA); these quantitative parameters do not depend on the level of the renal function. They are calculated at the end of the dynamic part of the renogram and on the late post-micturition post-erect images. Normal and abnormal values have been determined (Piepsz et al. 2002; Nogarède et al. 2010).
Evaluating the prognosis of these patients on the basis of the analysis of the DRF and drainage remains a challenge and is still controversial (Piepsz et al. 2009; Piepsz 2009; Gordon et al. 2011; Ismaili and Piepsz 2013). Normal drainage strongly suggests the absence of risk for functional deterioration (Piepsz 2009), but impaired drainage does not allow predicting the outcome if a conservative approach is chosen. Several recent studies strongly suggest the importance of the visual analysis of the cortical transit time of the tracer as a prognostic factor (Schlotmann et al. 2009; Piepsz 2011; Duong et al. 2013): severely delayed cortical transit time is associated with a high rate of improvement after surgery (Fig. 10). It also predicts functional deterioration in the absence of surgical treatment. However, a normal cortical transit does not exclude the risk of DRF deterioration.
2.5 The Postnatal Work-Up of Nephropathies
The group of nephropathies with antenatal diagnosis encompasses a large spectrum of diseases with variable degree of renal functional impairment. The largest group includes renal cystic diseases (see chapters “Renal Agenesis, Dysplasia, Hypoplasia and Cystic Diseases of the Kidney” and “Imaging in Renal Agenesis, Dysplasia, Hypoplasia and Cystic Diseases of the Kidney”). The renal involvement will be confirmed by postnatal US. The presence of small cysts is sometimes easier to detect after birth than in utero, and this will help to precise the diagnosis (Fig. 11). US will also be helpful to detect associated malformations especially those occurring in the genital tract, the liver, and the pancreas. The rest of the work-up will mainly be focused on clinical, biological, and genetic data that must be evaluated in order to characterize the diseases or syndromes (Avni et al 2006, 2012). US will be used during childhood in order to follow the renal growth and eventually changing US patterns with time (Fig. 12.).
For multicystic dysplastic kidney, renal ectopia, or unilateral agenesis, the work-up should also include US and a VCUG, if US is abnormal (see above) in order to detect ipsi- or contralateral VUR. Again, high-grade VURs might require prophylactic antibiotic therapy (Atiyeh et al. 1993; Flack and Bellinger 1993; Selzman and Elder 1995; Ismaïli et al 2005). Also of interest is to search for associated genital anomalies on pelvic US (Tables 2a and 2b).
Take away
The postnatal work-up of urinary tract anomalies has now been standardized, US being the cornerstone. Depending on the result, VCUG (or ce-VUS), MRI, and/or isotopes will be performed in order to clarify the diagnosis and choose the proper treatment.
3 Long-Term Follow-Up and (Potential Treatment) in the Light of the Natural History of Uro-nephropathies
As mentioned above, antenatal diagnosis has led to dramatic changes in the management of uropathies. First, nowadays, most patients are asymptomatic; second, the medical follow-up of many pathologies confirms their potential to resolve spontaneously. Consequently, surgery has been less and less advocated. The main goal of the prophylactic treatment (if applied) is to prevent further renal damage during the period when spontaneous resolution is expected. It should be noted that infection does occur in some cases despite the prophylactic antibiotic therapy; these cases make alternative treatment necessary (Jaswon et al. 1999; Ismaïli et al. 2006; Lee et al. 2006).
3.1 Vesicoureteric Reflux
Many series have shown that two-thirds of neonatal VURs (mainly grades I-III) are likely to resolve or at least to improve during an observation period of 2 years (Fig. 13). Therefore, once the anomaly is detected, the patient is given prophylactic antibiotic therapy (in cases of high-grade VUR) and followed clinically or by imaging as described above. In some circumstances, another therapeutic approach (surgery or endoscopic injection of bulging agents) should be proposed: in the case of breakthrough infection despite therapy, if there is failure to thrive, or if continuing the treatment is problematic for the family (Herndon et al. 1999; Burge et al. 1992; Bouachrine et al. 1996; Assael et al. 1998; Ismaïli et al. 2006; Van Eeide et al. 2007) (see chapters “UTI and VUR” and “Vesicoureteric Reflux”).
3.2 Pelvi-ureteric Junction (PUJ) Obstruction
The therapeutic management of PUJ obstruction has been even more controversial than for VUR. Advocates and opponents of neonatal surgery have published large amounts of scientific material that shows opposite or contradictory results. For some, early surgery is safe and improves renal function notably. For others, the PUJ obstruction has been present for a long time, and there is only a faint chance of improving the condition by surgery, especially since the dilatation itself may resolve spontaneously (Fig. 14). Others suggest operating only those patients who would show functional deterioration. Finally, some suggest following renal growth on US and operating when the contralateral kidney displays compensatory growth.
On the basis of all the data accumulated, conservative management seems the most adequate in mild or moderate cases. Clinical status, renal anomalies, and renal function must be monitored closely. Regular US examinations should be performed (every 6 months, during the first 2 years; every year later – possibly with standardized and comparable hydration). In most cases, the dilatation will be stable or even resolve. Surgery must be proposed if clinical symptoms appear or if renal function and/or cortical transit deteriorate. In rare and severe cases, spontaneous resolution is less likely to occur and symptoms related to abdominal discomfort are more frequent. For such patients, surgery may be beneficial even without other signs of deterioration (Docimo and Silver 1997; Duckett 1993; Capolicchio et al. 1999; McAleer and Kaplan 1999; Chertin et al 1999; Salem et al. 1995; Thorup et al. 2003).
3.3 Ureterovesical Junction (UVJ) Obstruction
Like VUR, UVJ obstruction has shown great potential for spontaneous resolution, probably because of the maturation of the UVJ (Fig. 15). Therefore, after completion of the initial work-up, a prophylactic antibiotic therapy should be started and the urinary tract monitored by US (possibly with standardized and comparable hydration and bladder filling) and eventually functional isotope studies (or fMRU). US may underestimate the drainage impairment, especially since the renal pelvis may not be dilated. Therefore, before confirming complete resolution or before surgery particularly in a more complex anatomy, morphological assessment of the urinary tract may be necessary – best achieved by MR urography (Baskin et al. 1994; Liu et al. 1994; Shukla et al. 2005).
3.4 Multicystic Dysplastic Kidney (MCDK)
Once the diagnosis of a MCDK appears highly probable (on the basis of the neonatal US examination and on the lack of function demonstrated by nuclear medicine studies or MRI), a clinical and imaging (US) follow-up is the most widely accepted approach. In two-thirds of cases, a MCDK diagnosed in utero will involute spontaneously within the first 2 years of life; the involution may already start in utero (Fig. 12). Complications are very unusual. Only very large MCDKs causing abdominal discomfort and without resolution on follow-up examinations will require surgical removal (Hrair-Georges et al. 1993; Rabelo et al. 2006; Aslam and Watson 2006).
3.5 Complicated Duplex Kidneys
In case of complicated duplex collecting systems, one of the aims of imaging will be to differentiate between an ectopic ureteral insertion and an ectopic ureterocele. An extravesical ectopic ureter insertion with a functional upper renal pole will lead to the reimplantation of the ureter (with or without modeling) in the bladder or its anastomosis into the lower renal pole ureter. A nonfunctioning upper pole with an extravesical ectopic ureter will bring us to an upper pole heminephrectomy and ureterectomy by lomboscopy in case of significant renal pelvis dilatation or infection. An extravesical or an obstructive ureterocele will be punctured or unroofed by cystoscopy before the child is discharged from the maternity hospital (Fig. 4). In case of a pyelonephritis, depending of the renal moieties function and/or if there is a VUR, an upper or lower heminephrectomy with ureterectomy will be proposed or the removal of the ureterocele and the reimplantation of both ureters (Uphadhyay et al. 2002; Husman et al. 1999; Blyth et al. 1993).
3.6 Nephropathies
Congenital nephropathies will be managed individually; the work-up and follow-up are tailored case-by-case and will depend upon the clinical presentation. Some patients will have signs of renal failure directly at birth, while for others the renal failure will develop progressively later in childhood or even only during adult life. Some patients will display only renal symptoms; for others, other organs and systems may be involved (the brain, pancreas, liver, etc.). For the latter, complementary examinations will be necessary (MRI, CT, etc.).
In most cases, US will be sufficient for the follow-up (Fig. 16). Still, imaging will have to be adapted to the type and degree of the anomaly (Avni et al. 2006, 2012).
Take away
US is the main imaging technique that will be used for diagnosis and the follow-up of all uro-nephropathies. Depending on clinical and biological data, the management will be adapted. If necessary, MRI and isotopes will be used to provide anatomical and functional information.
Conclusions
US is the cornerstone of the work-up of congenital uropathies at birth and during follow-up. The use of other techniques will depend on the US findings at birth. MR imaging and isotopes will help to determine the anatomy and the function of the urinary tract. Apart from acute conditions requiring immediate treatment, the therapeutic approach to congenital uropathies is less and less surgical. Prophylactic antibiotic therapy may be initiated at birth in severely dilated cases.
References
Adeb M, Daye K, Dihlman JR et al (2013) MR urography in evaluation of duplicated renal collecting systems. MRI Clin N Amer 21:717–730
Aslam M, Watson AR (2006) Unilateral MDK: long-term outcomes. Arch Dis Child 91:820–823
Assael BM, Guez S, Marra E et al (1998) Congenital reflux nephropathy: a follow-up of 108 cases diagnosed perinatally. Br J Urol 82:252–257
Atiyeh B, Husmann D, Baum M (1993) Contralateral renal abnormalities in patients with renal agenesis and non-cystic renal dysplasia. Pediatrics 91:812–815
Avni EF, Ayadi K, Rypens F et al (1997) Can careful ultrasound examination of the urinary tract exclude vesicoureteric reflux in the neonate. Br J Radiol 70:977–982
Avni EF, Bali MA, Regnault M et al (2000) MR urography in children. Eur Radiol 43:154–166
Avni EF, Garel L, Cassart M et al (2006) Perinatal assessment of hereditary cystic renal diseases. Pediatr Radiol 36:405–416
Avni FE, Garel C, Cassart M et al (2012) Imaging and classification of congenital cystic renal diseases. AJR Am J Roentgenol 198:1004–1013
Barbosa JA, Chow J, Benson CB et al (2012) Postnatal longitudinal evaluation of children diagnosed with prenatal hydronephrosis. Prenat Diagn 32:1242–1249
Baskin LS, Zderic SA, Snyder HM et al (1994) Primary dilated megaureter long-term follow-up. J Urol 152:618–621
Blyth B, Passerini Glazel G, Camuffo C et al (1993) Endoscopic incision of ureteroceles intravesical versus ectopic. J Urol 149:556–560
Bouachrine H, Lemelle JL, Didier F et al (1996) A follow-up study of pre-natally detected primary VUR: a review of 61 patients. Br J Urol 78:936–939
Bouzada MCF, Oliveira FA, Pereira AK et al (2004) Diagnostic accuracy of postnatal pelvic diameter as a predictor of uropathy. Pediatr Radiol 34:798–804
Burge DM, Griffiths MD, Malone PG et al (1992) Fetal VUR outcome following conservative management. J Urol 148:1743–1745
Capolicchio G, Leonard MP, Wong C et al (1999) Prenatal diagnosis of hydronephrosis: impact on renal function. J Urol 162:1029–1032
Chertin B, Fridman A, Knizhnik M et al (1999) Does early detection of UPJ obstruction improve surgical outcome? J Urol 162:1037–1040
Darge K, Higgins M, Hway TJ et al (2013) MR and CT in pediatric urolody. Radiol Clin N Am 51:583–598
Docimo SG, Silver RI (1997) Renal ultrasonography in newborns with prenatally detected hydronephrosis: why wait? J Urol 157:1387–1389
Duckett JW (1993) When to operate on neonatal hydronephrosis. Urology 42:617–619
Duong HP, Piepsz A, Collier F et al (2013) Predicting the clinical outcome of antenatally detected unilateral pelviureteric junction stenosis. Urology 82:691–696
Ek S, Lindefeldt KJ, Vanicio L et al (2007) Fetal hydronephrosis: prevalence, natural history and postnatal consequences in an unselected population. Acta Obstet Gynecol 86:1463–1466
Eskild-Jensen A, Gordon I, Piepsz A et al (2004) Interpretation of the renogram : problems and pitfalls in hydronephrosis in children. BJU Int 94:887–892
Flack CE, Bellinger MF (1993) The multicystic dysplastic kidney and contralateral vesicoureteral reflux protection of the solitary kidney. J Urol 150:1873–1874
Gordon I, Colarinha P, Piepz A et al (2001) Guidelines for standard and diuretic renography in children. Eur J Nucl Med 28:BP21–BP30
Gordon I, Piepsz A, Sixt R (2011) Guidelines for standard and diuretic renogram in children. Eur J Nucl Med Mol Imaging 38:1175–1188
Hagg MJ, Mourachov PV, Snyder HM et al (2000) The modern endoscopic approach to ureterocele. J Urol 163:940–943
Herndon CDA, McKenna PH, Kolon TF et al (1999) A multicenter outcomes analysis of patients with neonatal reflux presenting with prenatal hydronephrosis. J Urol 162:1203–1208
Hrair-Georges JM, Rushton HG, Bulas D (1993) Unilateral agenesis may result from in utero regression of MDK. J Urol 150:793–794
Hulbert WC, Rosenberg HK, Cartwright PC et al (1992) The predictive value of ultrasonography in evaluation of infants with posterior urethral valves. J Urol 148:122–124
Husman D, Strand B, Ewalt D et al (1999) Management of ectopic ureterocele associated with renal duplication. J Urol 162:1406–1409
Ismaïli K, Avni FE, Wissing JK et al (2004) Long term outcome of infants with mild and moderate fetal pyelectasis: validation of neonatal US as a screening tool to detect significant nephro-uropathy. J Pediatr 144:759–765
Ismaïli K, Avni FE, Alexander M et al (2005) Routine VCUG is of no value in neonates with unilateral MDK. J Pediatr 146:759–763
Ismaïli K, Hall M, Piefz A et al (2006) Primary VUR detected in neonates with a history of fetal renal pelvis dilatation. J Pediatr 148:222–227
Ismaili K, Piepsz A (2013) The antenatal detected pelvi-ureteric junction stenosis: advances in renography and strategy of management. Pediatr Radiol 43:428–435
Jaswon MS, Dibble L, Puri S et al (1999) Prospective study of outcome in antenatally diagnosed renal pelvis dilatation. Arch Dis Child Fetal Neonatal Ed 80:F135–F138
Kousidis G, Thomas DFM, Morgan H, Haider N et al (2008) The long term follow-up of prenatally detected PUV: a 10 to 23 year follow-up study. BJU Int 102:1020–1024
Kumar S, Walla S, Ikpene O (2012) Post natal outcome of prenatally diagnosed renal pelvic dilatation. Prenat Diagn 32:519–522
Lee RS, Cendron M, Kinnamon DD et al (2006) Antenatal hydronephrosis as a predictor of postnatal outcomes: a meta-analysis. Pediatrics 118:586–593
Liu HYA, Dhillon HK, Yeung CK et al (1994) Clinical outcome of prenatally diagnosed primary megaureters. J Urol 152:614–617
Marra G, Barbieri G, Dell’Agnola CA et al (1994) Congenital renal damage associated with primary vesicoureteral reflux detected prenatally in male infants. J Pediatr 124:726–730
McAleer IM, Kaplan GW (1999) Renal function before and after pyeloplasty: does it improve? J Urol 162:1041–1044
Morris RK, Malin GL, Khan KS, Kitty MD (2009) Antenatal US to predict post natal renal function in congenital lower urinary tract obstruction: systematic review of test accuracy. BJOG 116:1290–1299
Nogarède C, Tondeur M, Piepsz A (2010) Normalized residual activity and output efficiency in case of early furosemide injection in children. Nucl Med Commun 31:355–358
Nguyen HT, Herndon CDA, Cooper C, Gatti J, Kirsch A, Kokorowski P et al (2014) The Society for fetal urology consensus statement on the evaluation and management of antenatal hydronephrosis. J Pediatr Urol 6:212–231
Pates JA, Dashe JS (2006) Prenatal diagnosis and management of hydronephrosis. Early Hum Dev 82:3–8
Piepsz A, Kuyvenhoven J, Tondeur HH (2002) Normalized residual activity: usual values and robustness of the method. J Nucl Med 43:33–38
Piepsz A, Ham HR (2006) Pediatric applications of renal nuclear medicine. Semin Nucl Med 36:16–35
Piepsz A (2011) Antenatal detection of pelviureteric junction stenosis : main controversies. Semin Nucl Med 41:11–19
Piepsz A, Tondeur M, Nogarède C et al (2011) Can severely impaired cortical transit predict which children with pelvi-ureteric junction stenosis detected antenatally might benefit from pyeloplasty ? Nucl Med Commun 32:199–205
Piepsz A, Gordon I, Brock J 3rd et al (2009) Round table on the management of renal pelvic dilatation in children. J Pediatr Urol 5:437–444
Piepsz A (2009). The predictive value of the renogram. Eur J Nucl Med Mol Imaging 36:1661–1664
Prigent A, Cosgriff P, Gates GF et al (1999) Consensus report on quality control of quantitative measurements of renal function obtained from renogram : International Consensus Committee for the Scientific Committee of Radionuclides in Nephrourology. Semin Nucl Med 29:146–159
Quirino IG, Diniz JSS, Bouazada MCF et al (2012) Clinical course of 822 children with prenatally detected nephron-uropathies. Clin J Amer Soc Nephrol 17:444–451
Rabelo EAS, Oliveira EA, Silva JMP et al (2006) US progression of prenatally detected MDK. Urology 68:1098–1112
Renkema KY, Winyard PJ, Skovorodkin IN et al (2011) Novel perspectives for investigating CAKUT. Nephrol Dial Transplant 26:3843–3851
Riccabona M, Avni FE, Blickman JG, Dacher JN, Darge K, Lobo ML, Willi UV (2008) Imaging recommendations in paediatric uroradiology: minutes of the ESPR workgroup session on urinary tract infection, fetal hydronephrosis, urinary tract US and voiding cystourethrography. Pediatr Radiol 38:138–145
Riccabona M, Avni EF, Blickman JG et al (2009) Imaging recommendations in paediatric uroradiology. Minutes of the ESPR uroradiology task force session on childhood obstructive uropathy, high-grade fetal hydronephrosis, childhood haematuria, and urolithiasis in childhood. ESPR Annual Congress, Edinburgh, UK, June 2008. Pediatr Radiol 39:891–898
Salem YH, Majd M, Rushton HG (1995) Outcome analysis of pediatric pyeloplasty as a function of patient age presentation and differential renal function. J Urol 154:1889–1893
Schlotmann A, Clorius J, Clorius SN (2009) Diuretic renography in hydronephrosis: renal tissue tracer predicts functional course and thereby need for surgery. Eur J Nucl Med Mol Imaging 36:1665–1673
Selzman AA, Elder JS (1995) Contralateral vesicoureteral reflux in children with a multicystic kidney. J Urol 153:1252–1254
Shimada K, Matsumoto F, Kawagoe M, Matsui F (2007) Urological emergency in neonates with congenital hydronephrosis. Int J Urol 14:388–392
Shukla AR, Cooper J, Paytel RK, Carr MC, Canning DA, Zderic SA, Snyder HM (2005) Prenatally detected primary megaureter: a role for extended follow-up. J Urol 173:1353–1356
Smith T, Gordon I (1998) An update of radiopharmaceutical schedules in children. Nucl Med Commun 19:1023–1036
Stabin M, Taylor A Jr, Eshima D et al (1992) Radiation Dosimetry for technetium-99m-MAG3, technetium-99m-DTPA, and iodine-131-OIH based on human biodistribution studies. J Nucl Med 33:33–40
Thorup J, Jokela R, Cortes D, Nielsen OH (2003) The results of 15-years of consistent strategy in treating antenatally suspected PUJ obstruction. BJU Int 91:850–852
Tibballs JM, De Bruyn R (1996) Primary vesicoureteric reflux: how useful is postnatal ultrasound? Arch Dis Child 75:444–447
Uphadhyay J, Bolduc S, Braga L, Fahrat W et al (2002) Impact of prenatal diagnosis on the morbidity associated with ureterocele management. J Urol 167:2560–2565
Van Savage JG, Mesrobian HG (1995) The impact of prenatal US on the morbidity and outcome of patients with renal duplication abnormalies. J Urol 153:768–770
Van Eeide AM, Hentgent MH, de Jond TPVM et al (2007) VUR in children with prenatally detected hydronephrosis. Ultrasound Obstet Gynecol 29:463–469
Walsh G, Dubbins PA (1996) Antenatal renal pelvis dilatation: a predictor of vesicoureteral reflux? AJR 167:897–900
Weinberg B, Yeung N (1998) US sign of intermittent dilatation of the renal collecting system in ten patients with VUR. J Clin Ultrasound 26:65–68
Wiesel A, Queisser-Luft A, Clementi M, Bianca S, Stoll C (2005) Prenatal detection of congenital renal malformations by fetal ultrasonographic examination: an analysis of 709,030 births in 12 Europeans countries. Eur J Med Genetics 48:131–144
Wollenberg A, Neuhaus T, Willi UV, Wisser J (2005) Outcome of fetal renal dilatation diagnosed during the third trimester. Ultrasound Obstet Gynecol 25:483–488
Yerkes EB, Adams MC, Pope JC et al (1999) Does every patient with prenatal hydronephrosis need voiding cystourethrography. J Urol 162:1218–1220
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Avni, F., Tondeur, M., Priso, RH. (2018). Upper Urinary Tract Dilatation in Newborns and Infants and the Postnatal Work-Up of Congenital Uro-nephropathies. In: Riccabona, M. (eds) Pediatric Urogenital Radiology. Medical Radiology(). Springer, Cham. https://doi.org/10.1007/978-3-319-39202-8_26
Download citation
DOI: https://doi.org/10.1007/978-3-319-39202-8_26
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-39200-4
Online ISBN: 978-3-319-39202-8
eBook Packages: MedicineMedicine (R0)